Maternal Aneminin Perinatal Sonuçlara Etkisinin Değerlendirilmesi.

Background: To evaluate the effect of Maternal Anemia on Perinatal Outcomes in pregnant women who were hospitalized and delivered in Harran University Faculty of Medicine Gynecology and Obstetrics clinic in the last 1 year. Materials and Methods: The current study included pregnant women who were hospitalized and delivered in Harran University Faculty of Medicine, Department of Obstetrics and Gynecology between January 1, 2021 and December 31, 2021. The information of these pregnant women was analyzed retrospectively. In the study group, the hemog¬lobin value of the patients at the time of admission for delivery and the hemog¬lobin value in the 3rd trimester was determined to be lower than 11 g/dl. The control group consisted of pregnant women who gave birth between the same dates, had a hemoglobin value of 11 g/dl or higher at delivery a nd i n t he 3rd trimester a nd had no systemic disease. Patients w ere randomly selected. The groups were compared in terms of obstetric and perinatal outcomes. Results: A total of 100 pregnant women were included in this study with 50 pregnant women as the study group and 50 pregnant women as the control group. There was no difference between the groups in the rates of intrauterine growth retardation, normal and low birth weight babies, Apgar scores at 1 minute and 5 minutes, and hospitalization in the neonatal ward (p>0.05). The preterm delivery rate was higher in the anemia group compared to the control group (34% vs 14%, p=0.020). Conclusions: According to the data obtained in this study, the preterm delivery rate of the anemic group was statistically significantly higher than the control group. [ABSTRACT FROM AUTHOR]